Have questions?Contact Us
A Multicenter, Open Label Long-Term Safety Study of BHV3000 in the Acute Treatment of Migraine
38 million people suffer from migraine headaches. Are you one of them? If so, Bioclinica Research in Orlando is now enrolling volunteers to participate in a migraine research study. The purpose of this study is to evaluate safety and tolerability of BHV3000 (rimegepant).
Eligibility and Recruitment Information
|Eligible Ages||18 and up|
|Inclusion||Subjects with 4 - 14 moderate to severe migraines per month.|
|Exclusion||History of HIV disease.|